Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 1;27(6):742-744.
doi: 10.4103/aian.aian_430_24. Epub 2024 Sep 30.

Levetiracetam-Induced Parkinsonism: A Short Case Series

Thomas Mathew  1 , Amitoj S Chadha  1 , Sita Jayalakshmi  2 , Surabhi Garg  1 , Aditya H Ravindranath  1 , Uday Murgod  3 , Shagun Bhardwaj  1 , Pranjali Ektare  1 , Saji K John  1 , Raghunandan Nadig  1 , Gosala Rk Sarma  1
Affiliations

Levetiracetam-Induced Parkinsonism: A Short Case Series

Thomas Mathew et al. Ann Indian Acad Neurol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Savica R, Grossardt BR, Bower JH, Ahlskog JE, Mielke MM, Rocca WA. Incidence and time trends of drug-induced parkinsonism: A 30-year population-based study: Time trends of drug-induced parkinsonism. Mov Disord. 2017;32:227–34. - PMC - PubMed
    1. Zesiewicz TA, Sullivan KL, Hauser RA, Sanchez-Ramos J. Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington’s disease. Mov Disord. 2006;21:1998–2001. - PubMed
    1. Gatto E, Roca CU, Zesiewicz TA, Sullivan KL, Hauser RA, Sanchez-Ramos J. Open-label pilot study of levetiracetam (Keppra) for the Etcheverry JL, Fadel D. Levetiracetam-induced Parkinsonism in a Huntington disease patient. Clin Neuropharmacol. 2006;29:303–4. - PubMed
    1. Lyons KE, Pahwa R. Efficacy and tolerability of levetiracetam in Parkinson disease patients with levodopa-induced dyskinesia. Clin Neuropharmacol. 2006;29:148–53. - PubMed
    1. Belete D, Jacobs BM, Simonet C, Bestwick JP, Waters S, Marshall CR, et al. Association between antiepileptic drugs and incident parkinson disease. JAMA Neurol. 2023;80:183–7. - PMC - PubMed